One in Four U.S. Jails Offer All FDA-Approved Medications to Treat Opioid Use Disorder, According to JCOIN’s National Survey of Treatment Services in Jails

Findings from JCOIN’s Coordination and Translation Center In a new article published in JAMA, JCOIN researchers found that 27.6% of United States jails offer all three FDA-approved medications for opioid use disorder (MOUD)—methadone, buprenorphine, and naltrexone—to select individuals, and 16.9% offer them to anyone with opioid use disorder (OUD). Providing MOUD during incarceration creates an…

Read More